期刊文献+

4种化疗方案治疗晚期鼻咽癌的临床观察 被引量:11

Evaluation the efficacy of four regimens on treating patients with advanced nasopharyngeal carcinoma
下载PDF
导出
摘要 目的评价顺铂+5-氟尿嘧啶(PF)、多西紫杉醇+顺铂+5-氟尿嘧啶(DPF)、吉西他滨+顺铂(GP)和紫杉醇+卡铂(TC)等4种方案治疗晚期及复发转移鼻咽癌的近期疗效及毒副反应。方法同一化疗方案的病例列为1组。PF组19例,DPF组22例,GP组23例,TC组23例。分别总结4种方案的有效率、白细胞下降和恶心呕吐的发生率。并将DPF、GP、TC方案分别与PF方案的各项结果进行统计分析。结果 PF组、DPF组、GP组和TC组的有效率分别为42.11%、72.73%、78.26%、56.5%。DPF方案、GP方案有效率与PF方案相比差异有统计学意义(χ2=3.939,P=0.047和χ2=5.768,P=0.016)。Ⅲ~Ⅳ度白细胞下降发生率GP、TC方案与PF方案比较差异无统计学意义(P>0.05);而DPF方案较PF方案差异有统计学意义(χ2=12.897,P=0.001)。恶心呕吐的发生率4组方案均差异无统计学意义(P>0.05)。结论 :DPF、GP、TC方案均是治疗晚期及复发、转移鼻咽癌可供选择的化疗方案。 Objective To evaluate the short-term therapeutic effect,toxicity and side effects of Cisplatin+5-Fluorouracil(PF)regimen,Docetaxel+Cisplatin+5-Fluorouracil(DPF)regimen,Gemcitabine+Cisplatin(GP)regimen,and Paclitaxel+CBP(TC)regimen on treating advanced and recurrent nasopharyngeal carcinoma(NPC).Methods Nineteen cases were treated with PF regimen,22 cases with DPF regimen,23 cases with GP regimen and 23 cases with TC regimen.The response rate,the occurrence of leukocytopenia,nausea and vomiting in each group were calculated and statistically analyzed.Result The response rates of PF,DPF,GP,and TC regimen were 42.11%,72.73%,78.26% and 56.5%,respectively.The higher response rates in the regimens of DPF and GP comparing to regimen PF were statistically significant(χ^2=3.939,P=0.047;χ^2=5.768,P=0.016).The occurrence rate of Ⅲ~Ⅳ grade leukocytopenia was no significantly different among the GP,TC and PF regimens(P〈0.05).The difference between regimen DPF and PF was statistically significant(χ^2=12.897,P=0.001).The differences of occurrence of nausea and vomiting among the four groups had no statistically significant(P〈0.05).Conclusion DPF,GP and TC are effective chemotherapy regimens for advanced and recurrent NPC.
出处 《中国癌症防治杂志》 CAS 2010年第2期112-115,共4页 CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
关键词 鼻咽癌 化学疗法 多西紫杉醇 吉西他滨 顺铂 5-氟尿嘧啶 Nasopharyngeal carcinoma Chemotherapy Docetaxel Gemcitabine Cisplatin 5-Fluorouracil
  • 相关文献

参考文献12

  • 1管忠震.鼻咽癌化学治疗的概况[J].癌症,1989,8(2):120-121. 被引量:66
  • 2张力,姜文奇,徐瑞华,管忠震.紫杉醇(Paclitaxel)治疗晚期鼻咽癌的临床研究[J].癌症,2000,19(8):811-813. 被引量:58
  • 3Airoldi M,Pedani F,Marchionatti S,et al.Carboplatin plus taxol is an effective third-line regimen in recurrent undifferentiated nasopharyngeal carcinoma[J].Tumor,2002,88(4):273-276.
  • 4Mu BB,Chan AT.Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngcl carcinoma[J].Cancer,2005,103(1):22.
  • 5Chua DT,Sham JS,Au GK.A phase Ⅱ study of capecitabine in pstients with recurrent and metastatic nssopharyngcal carcinoma pretrcated with platinum-based chemothetapy[J].Oral Oncol,2003,39(4):361.
  • 6L Cong SS,Wee J,Tay MH,et al.Paclitaxel,carboplatin,and gemcitabine in metastatic nasopharyngeal carcinoma:a Phase Ⅱ trial using a tripiet combination[J].Cancer,2005,103(3):569.
  • 7张天泽,徐光炜,主编.肿瘤学[M].第2版.辽宁:天津科学技术出版社,2005:1090-1107.
  • 8黄宏星.多西他赛用于肺癌、头颈部肿瘤和乳腺癌的研究结果公布[J].中国医药导刊,2006,8(4):311-312. 被引量:8
  • 9Chu DT,Sham JS,Au GK,et al.A phase study of docetaxel and cisplatin as firstline chemotherapy in patients with metastatic nasopharyngeal carcinoma[J].Oncol,2005,41(6):589-595.
  • 10Ngan RK,Yiu HH,Lau WH,et al.Combination gemcitabine and cisplatin chemotheray for metastatic or recurrent nasopharyngcal carcinoma:report of a phase Ⅱ study[J].Ann Oncol,2002,13(8):1252-1253.

二级参考文献4

共引文献121

同被引文献97

引证文献11

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部